InsidersTradesSigma
Heramed Limited Stock: price and directors' dealings · Australia · ASX
Track the Heramed Limited stock price and the full directors' dealings record of the company, a publicly traded company based in Australia. Shares are quoted on AU AU, under the supervision of ASX. Operating in the Health Care sector, Heramed Limited has logged 2 public disclosures. Market capitalisation: €48.7m. The latest transaction was filed on 3 July 2026 (Sale). Among the most active insiders: ANOUSHKA GUNGADIN. The full history is openly available.
2
Insider Decl.
0
Thresholds
·
1 ops.
Buy Volume
·
1 ops.
Sell Volume
11Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 19,687 of 25,936 companies
33.8
score / 100
Value18
Quality50
FCF yld-7.5%
Earn yld-8.5%
EV/EBITDA·
ROE-223%
Gross mgn100%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 3 July 2026
Declarations2 total
5,267,720 sharesShareASXASX:2924-03107666-2A1682269
2,500,000 sharesShareASXASX:2924-03082745-2A1668366
Ideal exit: 16 Jan 2027 (T+270)
2 of 2 declarations
About Heramed Limited
Heramed Limited is a company operating in the healthcare and pharmaceutical sector, listed on the XASX. It focuses on developing innovative solutions to enhance women's health.